Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673128 | SCV000798296 | uncertain significance | Retinitis pigmentosa 25 | 2018-03-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855590 | SCV002176311 | uncertain significance | not provided | 2022-09-06 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 2503 of the EYS protein (p.Glu2503Lys). This variant is present in population databases (rs768964978, gnomAD 0.06%). This missense change has been observed in individual(s) with retinitis pigmentosa (PMID: 21069908). ClinVar contains an entry for this variant (Variation ID: 557040). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000673128 | SCV002793564 | uncertain significance | Retinitis pigmentosa 25 | 2021-11-17 | criteria provided, single submitter | clinical testing |